Syringe News and Research

RSS

Reductions in syringe service program funding could increase overdose deaths

A new study published today in JAMA Network Open projects that reductions in federal funding for syringe service programs (SSPs) could lead to substantial increases in mortality among people who inject drugs in the United States.

18 Jun 2026

Public health messaging still beats AI chatbots for HPV vaccine promotion

The study finds that AI chatbots boost HPV vaccination intent temporarily, but public health resources are crucial for lasting impact on vaccination decisions.

10 Jun 2026

ISTA researchers prove keratin is indispensable for coherent cell migration

Hair, nails, and horns, all made up of keratin, are some of the hardest and most resilient structures in animals. Inside zebrafish cells, keratin plays a distinct role, giving them the strength they need to move together as a coherent tissue while modulating the driving forces behind their movement during early development. But what happens when keratin is missing?

22 May 2026

How media choices shape MMR vaccine hesitancy in the US

The study examines how media sources impact MMR vaccine attitudes, revealing a connection between non-mainstream outlets and increased vaccine hesitancy.

29 Apr 2026

Satellite livers could provide booster function for patients awaiting transplants

More than 10,000 Americans who suffer from chronic liver disease are on a waitlist for a liver transplant, but there are not enough donated organs for all of those patients.

4 Mar 2026

Social media muscle content raises steroid use intentions in young men

A study links muscle-focused social media content to increased intentions to use anabolic steroids among young men, highlighting risks of body comparison.

25 Feb 2026

Aptar Pharma’s intranasal solutions power CastleVax Phase II clinical trials for next-gen COVID-19 vaccine

In a significant step forward for mucosal immunity, Aptar Pharma has announced that its innovative nasal delivery systems are being utilized in CastleVax’s Phase II clinical trial for CVAX-01, an intranasal COVID-19 vaccine candidate.

From Hanson Wade Group - 4th Nasal Formulation & Delivery Summit 16 Feb 2026

Implantable immune scaffold predicts type 1 diabetes weeks before symptoms

The study highlights a presymptomatic phase in type 1 diabetes progression, using immune niches to track immune changes before blood sugar abnormalities.

4 Feb 2026

A high-protein diet shows strong anti-cholera effects

Cholera, a severe bacterial infection that causes diarrhea and kills if untreated, can be defeated with a diet high in protein, according to a new study from UC Riverside.

8 Jan 2026

Inside the battle for the future of addiction medicine

Elyse Stevens had a reputation for taking on complex medical cases. People who'd been battling addiction for decades. Chronic-pain patients on high doses of opioids. Sex workers and people living on the street.

7 Jan 2026

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Discover how Thermo Fisher’s handheld Raman and lab FTIR tools are transforming controlled substance testing with safer, faster, and more reliable results.

From Thermo Fisher Scientific – Pharmaceutical and Biopharmaceutical Solutions 14 Oct 2025

BD celebrates 55 years of manufacturing excellence and impact in Sumter, S.C. - Oct 3, 2025

BD (Becton, Dickinson and Company), a leading global medical technology company, today will commemorate 55 years of manufacturing excellence at its Sumter, South Carolina facility, which throughout its history has been a core site within the Company's extensive U.S. manufacturing footprint.

From BD (Becton, Dickinson and Company) 6 Oct 2025

An HIV outbreak in Maine shows the risk of Trump’s crackdown on homelessness and drug use

Penobscot County, Maine, is grappling with the largest HIV outbreak in the state's history. Home to Bangor, a city of roughly 32,000, the county has identified 28 new cases over nearly two years.

16 Sep 2025

Bacteria use density switch to balance virulence and growth

Pathogens are becoming more and more resistant to antibiotics. With the goal of developing new therapeutic approaches to treat bacterial infections more effectively in the future, researchers at the Karlsruhe Institute of Technology (KIT) and the Max Planck Institute in Marburg investigated the plague-related bacterium Yersinia enterocolitica.

12 Sep 2025

Breakthrough in protein drug delivery could replace lengthy IV infusions

Patients with some cancers, autoimmune diseases, and metabolic disorders often endure time-consuming intravenous (IV) infusions to receive the best protein-based treatments available.

20 Aug 2025

New injectable skin graft mimics dermis and promotes healing

Researchers have created what could be called "skin in a syringe". The gel containing live cells can be 3D printed into a skin transplant, as shown in a study conducted on mice.

12 Aug 2025

Deadly opioid contaminants uncovered in Adelaide street drug supply

A synthetic opioid 1000 times more potent than morphine is infiltrating the street drug trade in Adelaide, Australia, sparking fears of a wave of overdoses that could be lethal.

1 Aug 2025

Zinc from needle shields may contribute to syringe clogging

Employees of the technology transfer centre ANAXAM and researchers from the Paul Scherrer Institute PSI used the unique analytical methods available at PSI to look inside pre-filled syringes.

31 Jul 2025

Bacterial self-defense may hold clues to tackling antibiotic resistance

Researchers at the University of Southampton have worked out how bacteria defend themselves against viruses called phages and the new insights could be key to tackling antibiotic resistance.

28 Jul 2025

Kennedy’s vaccine advisers sow doubts as scientists protest US pivot on shots

As fired and retired scientists rallied outside in the Atlanta heat, an advisory panel that Robert F. Kennedy Jr. handpicked to replace experts he'd fired earlier met inside the Centers for Disease Control and Prevention's headquarters to plan a more skeptical vaccine future.

27 Jun 2025